Elanco Animal Health Stock Performance Falls 0.32%

Elanco Animal Health Inc. (ELAN) has recently seen its stock price decline significantly, trading nearly 50% below its 52-week high, with a notable loss of 29.72% over the past year. Despite these declines, the stock experienced a recent weekly uptick and maintains an average analyst recommendation of moderate buy, with a 1-year price target of $14.14. Analysts expect modest EPS growth of 16.43% next year despite a projected decline this year, and the company's historical five-year annual growth rate stands at 29.95%. Institutional investors hold a minority stake, and the stock's valuation ratios, such as price-to-book and price-to-sales, suggest it is trading below historical averages. Overall, while recent performance has been weak, analysts retain some optimism about Elanco's future prospects.